Mirae Asset Global ETFs Holdings’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.71M Sell
25,446
-1,566
-6% -$390K 0.01% 792
2025
Q4
$6.51M Sell
27,012
-25,193
-48% -$6.44M 0.01% 733
2025
Q3
$14.3M Buy
+52,205
New +$14.3M 0.02% 535
2025
Q2
Sell
-40,320
Closed -$9.03M 3200
2025
Q1
$9.03M Sell
40,320
-241
-0.6% -$56.3K 0.02% 611
2024
Q4
$9.28M Sell
40,561
-3,082
-7% -$742K 0.02% 585
2024
Q3
$10.7M Sell
43,643
-3,341
-7% -$747K 0.02% 534
2024
Q2
$8.99M Buy
+46,984
New +$9.53M 0.02% 575

Other funds holding RMD

Mirae Asset Global ETFs Holdings's RMD Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings reduced its ResMed (RMD) stake by 5.8% in Q1 2026, selling an estimated $390K and leaving 25,446 shares worth $5.71M. The position accounts for 0.01% of the portfolio, ranked #792.

Mirae Asset Global ETFs Holdings first reported a position in RMD in Q2 2024 and has held it in 7 quarters since. The position peaked at $14.3M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 25,446 shares of ResMed worth $5.71M as of Q1 2026.
  • Mirae Asset Global ETFs Holdings sold 1,566 ResMed shares in Q1 2026, an estimated $390K.
  • ResMed made up 0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #792 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in ResMed in Q2 2024 and has held it in 7 quarters since.
  • Mirae Asset Global ETFs Holdings's ResMed position peaked at $14.3M in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.